Buy Immunomedics Stock | IMMU Stock Price & Latest News | Public

Immunomedics

$0.00 (0.00%)Today

About IMMU

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered i...Read more

Community

People who own or watch this stock

News

News image
Shares of Immunomedics jump on positive confirmatory data for its breast-cancer drug
0
0
News image
Shareholder Alert: Robbins LLP Reminds Investors Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion to Dismiss
0
0

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1.4

Price Targets

What analysts think this stock will be worth

$39.96
current
$44.60
average

Events

List of events that could affect this stock.

06May

Earnings data Q1 2020

05Aug

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-0.17
-0.33
-0.5
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$0.36

Actual EPS
Q3 2020

Stats

Market Cap$9,54B
Volume141,02k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$42.94
1 Year Low$8.80
Open$41.43
High$42.48
Low$39.67

Buy any stock with any amount of money.

Download the App
Download the app